SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-049797
Filing Date
2017-08-07
Accepted
2017-08-07 11:50:13
Documents
56
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a17-13366_110q.htm 10-Q 918194
2 EX-31.1 a17-13366_1ex31d1.htm EX-31.1 9537
3 EX-31.2 a17-13366_1ex31d2.htm EX-31.2 9493
4 EX-32.1 a17-13366_1ex32d1.htm EX-32.1 7323
  Complete submission text file 0001104659-17-049797.txt   5757636

Data Files

Seq Description Document Type Size
5 EX-101.INS fold-20170630.xml EX-101.INS 1329262
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fold-20170630.xsd EX-101.SCH 41325
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fold-20170630_cal.xml EX-101.CAL 60208
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fold-20170630_def.xml EX-101.DEF 190903
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT fold-20170630_lab.xml EX-101.LAB 487234
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fold-20170630_pre.xml EX-101.PRE 338940
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33497 | Film No.: 171010626
SIC: 2834 Pharmaceutical Preparations